The "Small Organ" That Influences the Success of Cancer Treatment: New Possibilities for Immunotherapy Suggested by the Thymus

Deep within the chest, behind the sternum, lies a small organ that is rarely given much thought. Its name is the "thymus." Unlike well-known organs such as the heart or lungs, it is seldom a topic of conversation during health check-ups. For many, it might be considered a mundane organ that exists only in medical textbooks.

However, the thymus is now attracting attention for its potential role in determining the success of cancer treatment, particularly immunotherapy.

In an article dated July 6, 2026, the German newspaper WELT highlighted the possibility that the health of the thymus could affect the efficacy of cancer treatment. The publicly available section of the article discusses how a healthy thymus might teach immune cells the ability to "distinguish pathological tissues," thereby aiding in the immune attack on tumors. Previously considered an organ that shrinks after puberty, the thymus has returned to the forefront of discussions about adult cancer treatment and healthy longevity.

What is the Thymus? The "School of Immunity" for T Cells

The thymus is an organ belonging to the lymphatic system, located behind the sternum and above the heart. It is not prominent in size, and it has been thought to be relatively active in youth, gradually being replaced by adipose tissue with age.

The most important role of the thymus is to mature T cells. T cells are a type of immune cell that identifies and attacks virus-infected or cancerous cells. However, it is not enough for T cells to simply multiply. They need to be trained to react to foreign invaders and abnormal cells while avoiding attacks on the body's own normal tissues.

The thymus serves as the "school" for this education. In the thymus, T cells learn what to consider an enemy and what to protect as part of themselves. If this education fails, the immune system may be too weak to detect infections or cancer. Conversely, if it runs amok, it could lead to autoimmune diseases where the body attacks itself.

Thus, the thymus is an organ involved not only in the strength of immunity but also in its "intelligence."

Why the Thymus Becomes Important in the Era of Immunotherapy

Cancer treatment has changed significantly over the past decade. In addition to surgery, chemotherapy, and radiation therapy, immunotherapy centered around immune checkpoint inhibitors has become a treatment option for many cancers.

Immune checkpoint inhibitors are drugs that release the "brakes" used by cancer cells to evade immune attacks. Simply put, they aim to restore the inherent attack power of the patient's immune cells and direct them against cancer.

However, they do not work equally for all patients. While some experience dramatic effects, others do not achieve sufficient results. In medical practice, PD-L1 expression, tumor gene mutation burden, cancer type, and the patient's overall condition have been used as clues to predict treatment efficacy.

Now, a new factor has emerged: the state of the patient's immune system itself.

Immunotherapy does not target cancer cells alone. It heavily depends on whether the patient's immune system can function. If the supply or diversity of T cells is insufficient, there may not be enough attack forces even if the brakes are released. Conversely, if the thymus is relatively healthy and capable of producing diverse T cells, the effectiveness of immunotherapy may be enhanced.

This perspective slightly shifts the view of cancer treatment. Traditionally, the focus has often been on "what kind of nature the cancer has." In the future, in addition to this, there may be a more detailed examination of "how capable the patient's immune system is of fighting."

AI Reads "Thymus Health" from CT Images

Recent research has particularly focused on attempts to analyze CT images with AI to quantify the state of the thymus.

A study published in Nature evaluated the "health of the thymus" by analyzing the size, shape, and composition of the thymus from CT images taken in routine clinical practice, targeting patients with various types of cancer who received immune checkpoint inhibitors. The study involved a large cohort, including 3,476 patients who underwent cancer immunotherapy.

The results indicated that among patients with non-small cell lung cancer, those with better thymus health tended to have lower risks of disease progression and death. Furthermore, similar associations between thymus condition and immunotherapy outcomes were reported for other cancer types, such as melanoma, kidney cancer, and breast cancer.

Importantly, this evaluation utilizes CT images taken during routine clinical practice, not special examinations. If further validation allows for clinical application, it could become a new indicator for predicting the effectiveness of immunotherapy without imposing significant additional burdens on patients.

The use of AI in medicine extends beyond merely detecting lesions. It is expanding to uncover information hidden in existing images, interpreting organ conditions and overall risk that were previously beyond human visual assessment. Thymus research is a symbolic example of this.

Emerging Connections with Healthy Longevity

Attention to the thymus is not limited to cancer treatment.

Another Nature paper by the same research group reported on the association between the health of the adult thymus and long-term health outcomes. Analyses using data from the National Lung Screening Trial and the Framingham Heart Study indicated that individuals with better thymus health tended to have lower risks of all-cause mortality, lung cancer incidence, and cardiovascular mortality.

According to a statement from Mass General Brigham, individuals with a high thymus health score had approximately 50% lower mortality risk, 63% lower cardiovascular mortality risk, and 36% lower lung cancer incidence risk compared to those with a low score.

Of course, this does not mean that "keeping the thymus healthy will necessarily extend lifespan." As it is an observational study, causality needs to be considered carefully. Whether a healthy thymus leads to longevity, whether individuals with better overall health tend to maintain a healthy thymus, or both, remains to be seen in future research.

Nevertheless, the possibility that the thymus is not merely a "child's immune organ" but an important organ reflecting adult health is gaining strength.

Factors That Age the Thymus and Potential Protectors

The publicly available section of the WELT article also touches on factors that may prematurely age the thymus and the potential for regeneration. Related research and reports suggest that smoking, obesity, chronic inflammation, metabolic abnormalities, and lack of exercise may be associated with declining thymus health.

This implies that the basics of lifestyle habits, rather than special supplements or expensive treatments, are fundamental to the foundation of immunity.

Avoid smoking. Maintain a healthy weight. Reassess lifestyles that exacerbate chronic inflammation. Exercise regularly. Get enough sleep. Manage blood sugar, blood pressure, and lipids. These general health habits may also be related to the youthfulness of immunity through the thymus.

However, caution is needed regarding alternative therapies or unverified supplements that claim to "rejuvenate the thymus." At present, there is no standard treatment for safely and reliably regenerating the thymus alone for the general public. Research efforts are underway to restore thymus function using mRNA technology, stem cell research, and tissue engineering, but it will take time to confirm efficacy and safety in humans.

While thymus research is intriguing, jumping to simplistic conclusions like "drinking this will make immunotherapy work" or "strengthening the thymus will prevent cancer" is dangerous.

Expectations and Caution Spread Simultaneously on Social Media

This topic is also generating reactions on social media.

On LinkedIn, medical and research professionals have shared the Nature paper, highlighting the point that "the thymus is a factory for T cells, and its health is related to the outcomes of immunotherapy." Unlike traditional biomarkers, which tend to focus on tumor-side information, the thymus is perceived as a new perspective for assessing "the patient's immune capability."

Additionally, SNS posts by prominent doctors and researchers have introduced the possibility that the thymus is related to healthy longevity, cancer, and the responsiveness to immunotherapy, sharing it in the context of "an organ long overlooked is being reevaluated."

On X, researchers are also conveying the message that "the thymus may be important for adult health," and there is interest in the evaluation method combining CT images and AI. It is noteworthy that the topic is gaining attention across different specialties, as it lies at the intersection of imaging diagnostics, tumor oncology, immunology, and aging research.

Meanwhile, on communities like Reddit, the idea that an organ once deemed unimportant might actually be related to cancer treatment and longevity is being shared with surprise. However, there are also calm comments noting that "it is an observational study, and causality has not been proven yet," and "while there is a connection with lifestyle habits, the thymus cannot be manipulated in isolation."

Reactions on social media can be broadly categorized into three streams.

The first is expectation. If the effectiveness of immunotherapy can be predicted from routine CT images, it would be significant for both patients and doctors. The accuracy of treatment selection could improve, and alternative treatment strategies could be considered earlier for patients who are less responsive.

The second is surprise. The thymus has been strongly associated with the image of an organ that "works in childhood and shrinks in adulthood." Many people find it unexpected that this organ might be related to adult cancer treatment and longevity.

The third is caution. While the research is promising, at this stage, it has only shown a correlation that "higher thymus scores tend to result in better outcomes." It has not been proven that directly improving the thymus will enhance the effectiveness of immunotherapy. Many experts and users with high medical literacy on social media emphasize this point.

From "Cancer-Focused Medicine" to "Patient's Immune-Focused Medicine"

Cancer medicine has long focused on how to attack cancer cells themselves. Where the tumor is located, how large it is, what genetic mutations it has, and which drugs it is susceptible to. This information remains extremely important.

However, in the era of immunotherapy, it becomes insufficient to look only at the cancer. Immunotherapy is a treatment that aims to restore the patient's immune system to a state where it can fight again, rather than directly killing the cancer with drugs.

In this context, the state of the patient's immune system is deeply related to the success of the treatment. The quality, diversity, and exhaustion level of T cells, inflammation status, gut environment, metabolism, and the thymus—all these are "host-side conditions" in the battle against cancer.

Research measuring thymus health holds the potential to advance cancer treatment from "tumor-centric" to "simultaneously viewing the tumor and the patient's immune system."

Will the Medical Field Change Immediately?

So, will all cancer patients start having their thymus scores measured from tomorrow? The answer is, not yet.

For a new biomarker to be used in medical practice, several conditions must be met. First, the same results must be reproducible in different patient groups. Next, using that indicator must actually improve treatment plans and benefit patients. Furthermore, it is important that the measurement method is standardized and that variability between medical institutions is minimized.

In the future, personalized medicine might be realized where immunotherapy is actively used for patients with high thymus scores, while combination therapies or alternative strategies are considered for those with low scores. However, at present, it is not yet time to use research results directly in everyday clinical decision-making.

What patients can do now is to appropriately receive standard treatment in consultation with their primary doctor. Additionally, they should organize lifestyle habits related to immunity within scientifically reasonable limits, rather than through extreme methods.

Hope and Cautions Indicated by Thymus Research

Research surrounding the thymus is offering new hope for cancer treatment. The clues to unraveling why immunotherapy works for some and not others may be hidden not only within the tumor but also in the small organ deep in the patient's chest.

On the other hand, the larger the theme of hope, the more likely misunderstandings are to spread. Just because the thymus is important does not mean that merely strengthening the thymus will cure cancer. Similarly, a low thymus score does not necessarily mean that immunotherapy will be ineffective. Medical research follows a long path of discovering possibilities, carefully verifying them, and eventually connecting them to treatment.

Nevertheless, the renewed attention to the thymus holds significant meaning.

An organ once considered "not very useful in adults" may actually be a mirror reflecting the youthfulness of immunity, the responsiveness to cancer treatment, and healthy longevity. If AI can read the state of the thymus from CT images and help predict the effectiveness of immunotherapy, cancer medicine will become even more precise.

A small organ is posing big questions.

The power to fight cancer is not determined solely by the nature of the tumor. It also depends on how diverse, flexible, and properly trained the patient's immune system is. The thymus may quietly hold part of the answer.

Source URL

WELT: An article introducing the possibility that thymus health may be related to the success of cancer treatment.
https://www.welt.de/gesundheit/plus6a15659f3b7096456ac82c48/krebs-dieses-kleine-organ-entscheidet-mit-ueber-den-erfolg-der-therapie.html

Nature: A research paper on thymus health and immunotherapy outcomes in cancer patients.
https://www.nature.com/articles/s41586-026-10243-x

Nature: A research paper examining the association between adult thymus health and mortality, lung cancer, cardiovascular mortality, etc.
https://www.nature.com/articles/s41586-026-10242-y

Mass General Brigham: A research announcement on the potential involvement of the thymus in healthy longevity and cancer treatment response.
https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/thymus-critical-to-longevity-and-cancer-treatment

ESMO: Conference presentation and press release on thymus health and cancer immunotherapy responsiveness.
https://www.esmo.org/press-releases/study-shows-thymic-health-is-linked-to-cancer-patients-response-to-immunotherapy

National Cancer Institute: Basic explanation of the thymus location and T lymphocytes.